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Introduction
Platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-
3-phosphocholine) acts primarily as a mediator of inflam-
matory and allergic reactions, causing microvascular
leakage, smooth muscle contraction, endothelial adhesion
and general cell activation. In addition, PAF has been
implicated in asthma, HIV pathogenesis, carcinogenesis
and apoptosis [1–5]. In the brain, PAF acts as a synapse
messenger, induces transcription of the early-response
genes, and is involved in ischemia, seizures and long-term
potentiation [6–9]. In concert with the diversity of its bio-
logical functions, PAF is found throughout the body both
in the plasma and cell cytosol. Intra- and extracellular
levels of this phospholipid are tightly regulated at the
point of both biosynthesis and hydrolytic degradation.
The latter is catalyzed by enzymes with platelet-activating
factor acetylhydrolase (PAF-AH) activity, which remove
the acetyl group from the sn-2 position and can therefore
be classified as phospholipases A2 (PLA2) [10,11]. 
To date, several proteins showing PAF-AH activity have
been identified in various tissues and purified. Recently,
some of the genes coding for these enzymes have been
cloned. The trimeric brain PAF-AH(Ib) [12–14] contains
two highly homologous catalytic subunits, a 1 and a 2, that
have 63% amino acid sequence identity, but show no simi-
larity to other proteins. The crystal structure of the bovine
a 1 subunit has been recently determined at 1.7 Å resolu-
tion [15]. The protein is unusual in that it has a tertiary
fold of small GTPases and contains a Ser–His–Asp triad in
the active site.
Other common isoforms of PAF-AHs, distinct from the brain
heterotrimeric species, include the plasma acetylhydrolase
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Background:  Neutral lipases are ubiquitous and diverse enzymes. The molecular
architecture of the structurally characterized lipases is similar, often despite a lack
of detectable homology at the sequence level. Some of the microbial lipases are
evolutionarily related to physiologically important mammalian enzymes. For example,
limited sequence similarities were recently noted for the Streptomyces exfoliatus
lipase (SeL) and two mammalian platelet-activating factor acetylhydrolases
(PAF-AHs). The determination of the crystal structure of SeL allowed us to explore
the structure–function relationships in this novel family of homologous hydrolases.
Results: The crystal structure of SeL was determined by multiple isomorphous
replacement and refined using data to 1.9 Å resolution. The molecule exhibits
the canonical tertiary fold of an a /b hydrolase. The putative nucleophilic residue,
Ser131, is located within a nucleophilic elbow and is hydrogen bonded to
His209, which in turn interacts with Asp177. These three residues create a triad
that closely resembles the catalytic triads found in the active sites of other
neutral lipases. The mainchain amides of Met132 and Phe63 are perfectly
positioned to create an oxyanion hole. Unexpectedly, there are no secondary
structure elements that could render the active site inaccessible to solvent, like
the lids that are commonly found in neutral lipases. 
Conclusions:  The crystal structure of SeL reinforces the notion that it is a
homologue of the mammalian PAF-AHs. We have used the catalytic triad in SeL
to model the active site of the PAF-AHs. Our model is consistent with the site-
directed mutagenesis studies of plasma PAF-AH, which implicate Ser273,
His351 and Asp296 in the active site. Our study therefore provides direct
support for the hypothesis that the plasma and isoform II PAF-AHs are triad-
containing a /b hydrolases.
(pPAF-AH) [16] and the intracellular isoform II (iPAF-
AH(II)) [17]. These two isoforms are homologous, single-
polypeptide chain, proteins that have 43% amino acid
sequence identity. The plasma isoform (441 amino acids) is
the larger of the two, with a longer N terminus due to the
presence of the 17-residue secretion signal and a 24-residue
putative propeptide. Both proteins contain the GXSXG
motif found in esterases, lipases and other members of the
a /b hydrolase superfamily of enzymes, a motif which con-
tains a nucleophilic serine residue [18,19]. Site-directed
mutagenesis of pPAF-AH indicated that apart from
Ser273— found within the GXSXG motif— His351 and
Asp296 are also essential for catalytic activity [20]. The
three homologous residues in iPAF-AH(II) are Ser236,
Asp259 and His314. These observations suggested that the
two acetylhydrolases contain catalytic triads and are similar
in their three-dimensional structures to neutral lipases.
This is an intriguing point, because there are no a /b hydro-
lases known with exclusively phospholipase A2 activity.
It has been noted that iPAF-AH(II), and by implication
pPAF-AH, shows limited amino acid sequence similarities
to a lipase from Streptomyces exfoliatus [21]. In this paper,
we describe the crystal structure of the S. exfoliatus lipase
(SeL) refined at 1.9 Å resolution. This structure provides
convincing evidence that the three enzymes, along with a
related lipase from Moraxella sp., constitute a new family
of a /b hydrolases.
Results
The quality of the model
Two N-terminal residues in each of the two molecules in
the asymmetric unit were not resolved in the electron-
density map and were excluded from the model. The final
model contains two independently refined molecules,
each of 260 amino acids (residues 3–263), and a total of
705 water molecules. The stereochemical parameters of
the final model are listed in Table 1. Of all non-glycine
residues, 91.4% and 8.1% are in the most favored and
allowed regions of the Ramachandran plot, respectively.
The only residue outside this range, the catalytic Ser131,
has a e -conformation (see below). There are two cis-pep-
tides preceded by Pro241 and Pro257.
Overview of the structure
The mature extracellular S. exfoliatus lipase, SeL, is a
single polypeptide chain protein made up of 262 residues.
The core of the molecule has the canonical tertiary fold of
a/b hydrolases [19] and contains a central parallel
b sheet, sandwiched between two predominantly helical
connections (Figure 1). As in all other a / b hydrolases, the
central strand–turn–helix motif, which constitutes C-loop
4 on the carboxyl edge of the b sheet, has a stereo-
chemistry of a nucleophilic elbow. (The loops on the
C-terminal edge of the b sheet are consecutively named
from C-loop 1 to C-loop 8.) This sharp turn contains a
nucleophilic residue, Ser131, in a strained secondary
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Table 1
X-ray crystallographic data and refinement statistics.
Native Eu U I
X-ray data
Resolution (Å) 1.9 2.5 2.45 2.3
Total observations 235,302 78,321 89,907 91,222
Unique reflections 49,042 22,678 23,289 28,103
Completeness (%) 95.4 99.4 97.1 95.6
Rsym (%)* 5.4 8.1 8.5 9.0
Riso (%)† – 15.0 18.7 12.6
Phasing power (acentric/centric)‡ – 1.32/0.96 1.42/1.04 0.93/0.69
Metal sites (major/minor) – 2/0 4/0 4/2
Rcullis (acentric/centric)§ – 0.78/0.70 0.76/0.67 0.86/0.84
Refinement and stereochemical parameters
Resolution (Å) 7.5–1.9
R factor (%)# 14.0
Rfree (%)# 18.6
Rms bond distance (Å) 0.016
Rms bond angle (° ) 1.1
Rms planar distance (1–4) (Å) 0.037
<B> mainchain atom (rms) (Å2) 18.1(1.5)
<B> sidechain atom (rms) (Å2) 23.4(3.2)
*Rsym = å | Ii – <I> | / å Ii, where Ii is the intensity of the ith observation
and <I> is the mean intensity of the reflection.
†Riso = å |FPH–FP| / å |FP|, where FP and FPH are the structure factor
amplitudes for native and derivative crystals, respectively. 
‡Phasing power = < FH > / <e >, where < FH > is the mean heavy atom
contribution and <e > is the mean lack of closure.
§RCullis = å |/ å | FPH–FP |. #Rfactor = å |Fobs–Fcalc| / å |Fobs|; 5% of
reflections were set aside and used to calculate Rfree. The overall figure
of merit for data between 16.0 and 2.5 Å resolution is 0.593.
structure ( f = 67°, y = -125°), known as the e -conforma-
tion; the motif is a hallmark of a /b hydrolases [18,19]. 
The active site
Like most other a/b hydrolases, SeL contains a chymo-
trypsin-like Ser–Asp–His triad in the active site (Figure 2).
The three participating amino acids, Ser131, Asp177 and
His209, are found in the polypeptide chain in a sequence
typical for a /b hydrolases. Ser131 is located, as expected,
at the tip of the nucleophilic elbow (C-loop 4). The loca-
tion of the catalytic histidine is very similar to that estab-
lished for neutral lipases (i.e. within C-loop 7, following
the third b strand after the nucleophilic elbow). A similar
location of the catalytic histidine is observed in other a /b
hydrolases, notably C14:ACP thioesterase [22], haloalkane
dehalogenase [23] and bromoperoxidase [24]. The posi-
tion of the catalytic aspartate is also identical to that found
in most a /b hydrolases—with the exception of the pan-
creatic lipase (see below)—and is at the carboxyl end of
the second b strand following the elbow (C-loop 6). The
stereochemistry of the catalytic triad in SeL is identical to
that observed in other lipases, in that the nucleophilic
attack can be carried out on the re face of the scissile ester
bond, which— topologically— is equivalent to the si face
of peptide bonds [25]. 
To identify the hydrogen-bond donating groups, which
could form the oxyanion hole in SeL, we carried out a
least-squares overlap of the SeL model with the struc-
ture of the Rhizomucor miehei lipase (RmL) in complex
with n-hexylphosphonate [26]. We found that the main-
chain amide groups of residues Met132, immediately
downstream of the nucleophile, and Phe63 correspond
closely to those amides in the R. miehei lipase (Leu145
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Figure 1
H5
N C
b 1 b 2 b 3
b 4 b 5 b 6 b 7 b 8H2 H3 H4 b 9
+1 +2 –1X +2X +1X +1X +1X +1
*S131 *D177 *H209
C-loop 1
C-loop 2
C-loop 3 C-loop 4 C-loop 5 C-loop 6 C-loop 7 C-loop 8 -loop 8
H1
H6
(a)
(c)
(b)
Structure
The structure of SeL. (a) A stereo diagram showing the Ca backbone
of SeL with every 20th Ca labeled. (b) The tertiary fold of SeL and the
localization of the active site. The three catalytic residues are shown in
full and are labeled. Helices are labeled consecutively from H0 to H6,
b strands are labeled B1–B9 and depicted as arrows, which indicate
direction. The loops on the C-terminal edge of the b sheet are labeled
from C-L1 to C-L8. The nucleophilic elbow is made up of B5 and H3.
(Figure generated using RIBBONS [54].) (c) A diagram of the tertiary
fold showing the arrangement of the secondary structure elements in
SeL, within its overall a /b hydrolase architecture. The N-terminal short
helix H0 is omitted for clarity. The locations of the three catalytic
residues, Ser131, Asp177 and His209, are indicated.
and Ser82, respectively) which are known to form part of
the oxyanion hole (Figure 2). It is of interest to note that,
in RmL, Ser82 becomes oriented suitably for this func-
tion, only after a conformational change that leads to the
activation of the protein at an oil–water interface [26,27].
A similar phenomenon has been described for the human
pancreatic lipase, in which Phe77 undergoes a conforma-
tional change [28]. The fact that SeL appears to have a
pre-formed oxyanion hole suggests that the enzyme is
active in solution, in a way similar to cutinase [29,30].
Finally, the putative acyl-binding groove in SeL contains
several hydrophobic sidechains, including Trp156, Met132
and Val179.
Implications for the molecular structures of PAF-AHs
Figure 3 shows a sequence alignment of pPAF-AH and
iPAF-AH(II) with SeL and its homologue, the Moraxella
sp. lipase. The sequences align well in the core of the
fold; the fifteen residues that are invariant within the
family are in the core region. Moreover, there are 35
residues that are identical in SeL and iPAF-AH(II), and
31 identical in SeL and pPAF-AH. A total of 45 amino
acids found in SeL are conserved in either iPAF-AH(II)
or pPAF-AH. Strands 1 and 2, as well as helix H6, cannot
be aligned with credibility. Secondary structure predic-
tion for the PAF-AHs yields equally ambiguous results
(data not shown) and was not useful. This did not affect
the feasibility of the analysis of the structure–function
relationships in the active-site region, because the ambigu-
ous fragments are distant from the active center. 
Ser236 in isoform II (Ser273 in pPAF-AH) corresponds
to Ser131 in SeL, in concert with earlier suggestions that
this residue is the nucleophile. Similarly, His314 in
isoform II (His351 in pPAF-AH) corresponds to His209
in SeL. Asp177, the third member of the catalytic triad in
SeL, however, is not conserved in the acetylhydrolases,
in which it is replaced at the homologous site by an
asparagine residue (Asn281 in iPAF-AH(II) and Asn318
in pPAF-AH). In both PAF-AHs, another nearby site,
corresponding to Thr154 in SeL, instead contains an
aspartate residue (Asp259 in iPAF-AH(II) and Asp296 in
pPAF-AH). When we modeled an aspartate residue into
site 154 in SeL, we were able to rotate the conforma-
tional c 1 and c 2 angles of this residue in such a way that a
good hydrogen bond (< 3.0 Å, proper angles) was formed
between its O d 2 atom and the N e 1 atom of His209
(Figure 2). It follows that a migration of the catalytic
aspartate is indeed possible within the structural frame-
work provided by the SeL model. 
On the basis of the SeL model, the mainchain amides
of Phe237 and Leu122 (iPAF-AH(II) notation) par-
ticipate in the formation of the oxyanion hole. In order to
identify the residues involved in substrate binding and
specificity, we have superimposed the active-site model
of iPAF-AH(II) onto that of the a 1 subunit of the brain
PAF acetylhydrolase (see Figure 4). As a result, we found
that in iPAF-AH(II), Leu110, Phe257 and Trp261 are
involved in the acyl-binding pocket (corresponding
residues in pPAF-AH are Leu141, Phe294 and Trp298).
Interestingly, Trp261 — invariant in the family — is posi-
tioned in such a way that it appears to limit the length of
an acyl chain that might fit into the pocket to five, or
maximum six, carbons.
The most significant insertion in the structures of PAF-
AHs, over that of SeL, occurs in C-loop 3, close to the
active site. This site is topologically equivalent to that
containing the lid in the R. miehei family of lipases, of
which four crystal structures are known [31]. As this insert
is not found in SeL, we are not able to suggest its struc-
ture; however, secondary structure prediction indicates
high helical propensity along its entire length.
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Figure 2
The catalytic triad in SeL (center) and its
comparison with that found in the Rhizomucor
miehei lipase (PDB accession 3TGL; right)
and the model of the one in iPAF-AH(II) (left),
inferred from the SeL structure. The two
critical hydrogen bonds within the triad are
indicated and atoms are colored according to
type. Only the mainchain atoms are shown for
the two residues that contribute amide groups
to the oxyanion hole (see text).
Discussion
The refined atomic model of SeL provides significant
insight into structure–function relationships in its homo-
logues, the plasma and intracellular isoform II PAF-AHs.
SeL is a canonical a / b hydrolase and its fold is consis-
tent with that suggested by the amino acid sequences of
acetylhydrolases. It contains a typical chymotrypsin-like
triad, two residues of which, Ser131 and His209, are con-
served in acetylhydrolases. Interestingly, Asp177, which
completes the triad in SeL, is not conserved in the PAF-
AHs, and its function appears to be taken up in the latter by
an aspartate residue that in PAF-AHs resides within C-loop
3, rather than C-loop 4. Mutagenesis experiments on pPAF-
AH directed at this aspartate residue — Asp296 — have
shown that it is essential for catalysis [20] and our modeling
confirms that it can form an appropriate hydrogen bond
with the active site histidine. This interaction, however,
involves the syn- rather that the anti-orbital of the Od 2
atom of Asp296. Analogous stereochemistry has been
described in the human pancreatic lipase, where a similar
‘migration’ of the catalytic aspartate residue has occurred
in an apparently unrelated evolutionary event [32]. The
fact that we were easily able to model the interaction of
the new aspartate with the other residues in the catalytic
site both validates the model and rationalizes the results of
pPAF-AH mutagenesis.
The molecular architecture of SeL, and by implication
those of the plasma and isoform II enzymes, are closely
reminiscent of a /b hydrolases, such as dienelactone hydro-
lase [33], the C14:ACP thioesterase [22], haloalkane dehalo-
genase [23] and bromoperoxidase [24]. A minor deviation
in the structure of SeL is the presence of an additional
antiparallel b strand at the end of the sheet. It is not clear
if this strand is also found in acetylhydrolases, in which
C-terminal extensions may fold differently. In one aspect,
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Figure 3
                       B1
      
C-L1
     
B2
              B3      C-L2      H1           B4
PAF-AH hp 112     GTHWLMGNILR.LLFGSMTTPANWNSPLRP.GEK.YPLVVFSHGLGAFRTLYSAIGIDLASHGFIVAAVE 178
PAF-AH II  83     QFNKRCGGLLFNLAVGSCRLPVSWNGPFKT.KDSGYPLIIFSHGLGAFRTLYSAFCMELASRGFVVAVPE 147
S.e.  LIP  22     PYATSQTSVSSLVASGFGGGTIYY..PTST.ADGTFGAVVISPGFTAYQSSIAWLGPRLASQGFVVFTID  88
Morax LIP  24     PFSIRTKRISRQSAKGFGGGTIHY..PTNASGCGLLGAIAVVPGYVSYENSIKWWGPRLASWGFVVITIN  90
                                                   C-L3
PAF-AH hp 179     HRDRSASATYYFKDQSAAEIG......DKSWLYLRTLK.QEEETHIRNEQVRQRAKECSQALSLILDIDH 241
PAF-AH hi 148     HRDRSAATTYFCK.QAPEENQPTNESLQEEWIPFRRVEEGEKEFHVRNPQVHQRVSECLRVLKILQEVTA 204
S.e.  LIP  89     TNTTLDQPD...........................................................SR  99
Morax LIP  91     TNSIYDDPD...........................................................SR 101
                        H2                    B5  C-L4  H3               B6      C-L5
Ñ 
Ñ 
PAF-AH hp 242     GKPVKNALDLKFDMEQLKDSIDREKIAVIGHSFGGATVIQTLSEDQRFRCGIALDAWMFPLGDEVY.SRI 310
PAF-AH hi 205     GQTVFNILPGGLDLMTLKGNIDMSRVAVMGHSFGGATAILALAKETQFRCAVALDAWMFPLERDFY.PKA 273
S.e.  LIP 100     GRQLLSALDYLTQRSSVRTRVDATRLGVMGHSMGGGGSLEAAKSRTSLKAAIPLTGWNTDKTWPELRTPT 169
Morax LIP 103     AAQLNAALDNMIADDTVGSMIDPKRLGAIGWSMGGGGALKLATERSTVRAIMPLAPYH.DKSYGEVKTPT 170
                    B7 C-L6       H4              B8       C-L7          H5
                         Ñ  Ñ 
PAF-AH hp 311     PQPLFFINSEYFQYPANIIKMKKCYSPDKERKMITIRGSVHQNFADFTFATGKIIGHMLK..LKGDIDSN 379
PAF-AH hi 274     RGPVFFINTEKFQTMESVNLMKKICAQHEQSRIITVLGSVHRSQTDFAFVTGNLIGKFFSTETRGSLDPY 340
S.e.  LIP 170     LVVGADGDTVAPVATHSKPFYESLPGS.LDKAYLELRGASHFTPN……..TSDTTIAKYSISWLKRFIDSD 234
Morax LIP 171     LVIACEDDRIAETKKYANAFYKNA…..IGPKMKVEVNNGSHFCPSYRFNEILLS..KPGIAWMQRYINND 233
                     H6             B9
PAF-AH hp 380     VAIDLSNKASLAFLQKHLGLHKDFDQWDCLIEGDDENLIPGTNINTTNQHIMLQNSSGIEKYN..
PAF-AH II 341     EGQEVMVRAMLAFLQKHLDLKEDYNQWNNLIEGIGPSLTPGAPHHLSSL
S.e.  LIP 235     TRYEQFLCP..…..IPRPSTIAEYRGTCPHTS
Morax LIP 234     TRFDKFLCANENYSKSPRISAYDYKDPC
Structure
Multiple amino acid sequence alignment of Streptomyces exfoliatus
lipase (s.e. LIP), pPAF-AH, iPAF-AH(II) and the Moraxella lipase (Morax
LIP). The alignment starts with the first b sheet. The secondary
structure elements are shown above the alignment in red for b sheets
and green for helices. All secondary structure elements and loops are
labeled as in Figure 1b. Dots represent deletions. Red denotes invariant
amino acids; green denotes conserved amino acids (i.e. those that are
closely related in at least three of the four sequences); blue denotes
amino acids that are either conserved in the two PAF-AHs or the two
lipases. Triangles show the locations of the catalytic amino acids.
however, SeL differs significantly from the hitherto
described neutral lipases and from most other a / b hydro-
lases: it contains no insertion in any of its C-loops
(Figure 5). Such inserts, either folded into identifiable
domains [22–24,33] or forming secondary structure ele-
ments that undergo conformational changes during
catalytic events [31,34,35], are common in a / b hydro-
lases. They confer specificity on the enzymes, and in the
case of neutral lipases — notably the human pancreatic
lipase [36] and the fungal lipases from the R. miehei and
Geotrichum candidum families [31,34,35]—the ability to
adsorb to oil–water interfaces. In the lipase superfamily
[37], the ‘lid’ insert appears to be involved in the control
of substrate specificity. Thus, the pancreatic, hepatic and
lipoprotein lipases which contain large helical lids are
predominantly neutral lipases, whereas the guinea pig
lipase, which has a short mini-lid, can effectively func-
tion as a phospholipase A1 [38,39]. The more recently
discovered members of this family, the homologous aller-
gens from venoms of yellow jacket, wasp and hornet, are
similar to the guinea pig lipase in their structure and are
also phospholipases A1 [40,41]. Other factors must also be
involved, because the coypu lipase has a high phospho-
lipase activity even though it has a full-size lid [42]. The
kinetic properties of SeL, which have not been fully
characterized, are therefore of great interest.
In contrast to SeL, both PAF-AHs contain inserts in C-loop
3; this loop is topologically equivalent to that which con-
tains the lid in the R. miehei family of lipases. Secondary
structure prediction suggests that this insert is mostly
helical, although amphiphilicity is not obvious— inserts of
a similar size made of helix bundles have been observed in
other a /b hydrolases [23,24]. We suggest, therefore, that
the regions 189–239 in pPAF-AH and 157–202 in isoform
II constitute subdomains, or lids, that contribute to sub-
strate specificity—perhaps towards the phosphocholine
group—as well as to interfacial activation, which has been
reported in the case of pPAF-AH [43]. It is noteworthy that,
as far as we know, the PAF-AHs are the only a /b hydrolases
known that show exclusively phospholipase A2 activity.
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Figure 4
Model of the active site in iPAF-AH(II), based
on the SeL coordinates. The view is down
b strand B5, looking directly at the active site.
Key residues are labeled; the active site
serine residue is hidden beneath the acetate
group, as modeled from the crystal structure
of brain PAF-AH. Residues conserved
between SeL and iPAF-AH(II) are shown
using thick bonds. Hydrogen bonds are
shown using broken green lines, and the
water molecules that are believed to be
conserved in iPAF-AH(II) are shown as red
asterisks. The leaving acetate group is shown
in transparent van der Waals spheres and is
labeled Ac. Note that the positions of the two
oxygens of the acetate group are occupied
by water molecules in the SeL structure.
C-loop 3 of iPAF-AH(II) (thick green ribbon),
which contains an insert, is shown as it
appears in SeL, that is lacking the insert.
Figure 5
A diagram illustrating the lack of a lid, typical of neutral lipases, in SeL.
The structures of SeL and the Rhizomucor miehei neutral lipase (RmL)
were superimposed on the basis of their mainchain atoms from the
nucleophilic elbow and the catalytic triad. In orange we show the
resulting location of the RmL lid, for which there is no structural
analogue in SeL.
Although specificity toward PAF varies among PAF-AHs,
all these enzymes hydrolyze short-chain acyl groups, two to
six carbons in length, at position sn-2 of either PAF or a
related polar phospholipid [11]. The preference for short-
chain acyl groups constitutes the most distinctive functional
difference between these enzymes and the well-character-
ized secretory and cytosolic variants of PLA2. The brain
PAF-AH(Ib) is very specific for PAF, whereas the plasma
or the isoform II enzymes are more promiscuous and may
also hydrolyze pro-inflammatory products of the oxidation
of membrane phospholipids containing polyunsaturated sn-
2 acyl chains. We note that in the model of the active site
of iPAF-AH(II), the acyl-binding groove appears to have
room for a five to six carbon chain, and this limit is imposed
by the intruding sidechain of Trp261. The susceptibility
of polar phospholipids to the hydrolytic activity of pPAF-
AH is enhanced further by the presence of an w -carbonyl
moiety [44]. This could be rationalized by the presence of
specific amino acids in the putative lid, but in the absence
of a suitable structural model of this subdomain, the sugges-
tion remains speculative. 
Finally, our model rationalizes the molecular basis of the
autosomal recessive plasma PAF-AH deficiency associated
with severe asthma in Japanese children [45]. This genetic
disease has been linked to a missense mutation that intro-
duces a Phe fi Val change at position 279 in the amino
acid sequence of the enzyme. The molecular model,
which we propose for the pPAF-AH, implies that Val279
is located within the nucleophilic elbow motif, at the
interface of the H3 helix and the B5 strand. Introduction
of a bulky phenylalanine residue in this position must lead
to steric hindrance, which does not allow for the proper
folding of the elbow motif. We postulate that the mutation
does not directly affect the active site, but that it destabi-
lizes the structure and indirectly destroys the structural
integrity of the active site. A similar rational applies to the
inactive Gln281fi Arg mutant identified in a 72-year old
Japanese woman with a coronary artery disease and essen-
tial hypertension [46]. 
Biological implications
Platelet-activating factor (PAF) is a potent lipid mes-
senger, which participates in a plethora of physiological
responses and in particular in inflammatory cell activa-
tion. The levels of PAF, ubiquitous throughout the
organism, are controlled by the PAF acetylhydrolases
(PAF-AHs), which inactivate PAF by hydrolytic removal
of the acetate group from the sn-2 position. There are
many isoforms of PAF-AHs, found both in the cell
plasma, where they act on the extracellular pool of PAF,
and in the cytosol. There is limited information available
regarding the structure–function relationships within this
family of enzymes. The structures of neither the physio-
logically important plasma PAF-AH nor an evolutionarily
related intracellular isoform II have been elucidated.
Our investigation led to the determination of the crystal
structure of a microbial homologue of the two struc-
turally uncharacterized PAF-AHs. The enzyme that
we have studied, a neutral lipase from Streptomyces exfo-
liatus (SeL), shows approximately 20% amino acid
sequence identity with the acetylhydrolases. The crystal
structure reveals that the enzyme belongs to the super-
family of a / b hydrolases. The tertiary fold of proteins
in this class consists of a central, predominantly paral-
lel, b sheet with various, mostly helical, connections.
The active site in the SeL is made up of a catalytic triad
of Ser131, Asp177 and His209. Such constellations of
amino acids are commonly found in the active sites of
a /b hydrolases, many of which are neutral lipases.
The atomic model of the SeL, highly refined using data to
1.9 Å resolution, is of considerable use in the studies of
the structure–function relationships of the PAF-AHs. It
confirms that the acetylhydrolases are a /b hydrolases and
that their active sites contain catalytic triads. We were
further able to suggest that the PAF-AHs, unlike SeL,
contain a ‘lid’ insert in C-loop 4. We can therefore
postulate that this subdomain is responsible for the
enzyme’s substrate specificity and observed interfacial
activation — as it is in other lipases. These conclusions
set the stage for a thorough structural characterization of
PAF-AHs, using mutational and biochemical methods.
Materials and methods
Lipase expression and purification
SeL was purified from 1 l cultures of wild-type Streptomyces lividans
carrying the cloned SeL gene in the plasmid pB13, as described else-
where [47]. The microorganism was grown in Luria-Bertani medium
supplemented with 34% sucrose to obtain dispersed mycelial growth
and 25 µg/ml of thiostrepton. Cultures were inoculated with freshly har-
vested spores from several well-sporulated plates and incubated at
30°C. After 96 h, the mycelium were spun down and the supernatant
adjusted to 1 l with 10 mM phosphate buffer (pH 7.0) and filtered once
through Whatmann No.1 filter paper and twice through 0.45 µm pore
size Millipore filters to eliminate small mycelial fragments. Total protein
was precipitated with 70% saturated ammonium sulfate and collected
by centrifugation at 30,000 g for 30 min. The pellet was resuspended
in 20 ml of 10 mM phosphate buffer (pH 7.0), dialyzed extensively, and
centrifuged at 10,000 g for 20 min to remove insoluble material. The
supernatant was loaded onto a DEAE-cellulose column (10 ml bed
volume) equilibrated with the same buffer. Unbound proteins, that is
SeL and a contaminating 43 kDa protein, were collected and dialyzed
extensively against 10 mM phosphate buffer (pH 6.0) and loaded onto
a CM-cellulose column (10 ml bed volume) equilibrated with the same
buffer. The 43 kDa contaminating protein was eluted by slowly raising
the pH of the column from pH 6.0 to pH 7.5. SeL was eluted with
0.25 M KCl in 10 mM phosphate buffer (pH 7.5), concentrated to
about 5 mg/ml and stored in the presence of 0.001% NaN3.
Crystallization and X-ray data collection
Purified protein was dialyzed against 50 mM Tris-HCl buffer at pH
7.0 to a concentration of 5.0 to 7.0 mg/ml, measured by protein
assay BioRad (Kit II). Crystals were grown in hanging drops, consist-
ing of 3 m l of protein solution mixed with an equal volume of precipi-
tant (30% ammonium sulfate, 10% MME 2000, 6% PEG 6000 and
200 mM phosphate buffer, pH 7.5), and equilibrated against a 500 m l
reservoir of the latter. Crystals were grown at room temperature; they
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are monoclinic (P21), a = 77.5 Å b = 53.0 Å, c = 81.1 Å and b = 95.8° .
The calculated specific volume was 2.73 Å/Da for two molecules in the
asymmetric unit, suggesting an average solvent content of 54%. A
single crystal was used to collect the native data at room temperature,
using MacScience DIP-2020 scanner mounted on an Enraf-Nonius
RF591 generator. Heavy-atom derivatives were prepared by soaking
native crystals in mother liquid containing the following metal reagents:
5 mM EuCl2 for 10 hrs, 5 mM uranyl acetate for 24 hrs, 1.5 mM N-iodo-
succinimide for 8 hrs. DENZO and SCALEPACK [48] were used to
process the data. Table 1 shows the details of the experimental data.
Structure solution and refinement
The structure was determined by multiple isomorphous replacement
(MIR). All calculations were carried out using the CCP4 suite of pro-
grams [49], unless specified otherwise. Two Eu sites were clearly
resolved in isomorphous difference Patterson maps. Subsequent differ-
ence Fourier calculations were used to locate heavy atoms in the other
derivatives (see Table 1). Heavy-atom parameters were refined using
MLPHARE. The initially calculated MIR phases were solvent flattened
using SQUASH. The resulting electron-density map was readily inter-
pretable, and one of the two SeL molecules was built interactively
using the program O [50]. The position of the second molecule in the
asymmetric unit was obtained from this model and the Molecular
Replacement program AMORE [51]. For the initial model, the conven-
tional R factor was 37.5% (8.0–3.0 Å), and the coordinates were
refined using positional refinement with X-PLOR [52]. Simulated
annealing and B-factor refinement reduced R and Rfree to 24.2% and
28.5%, respectively, against data in the shell 8.0–1.9 Å (with 5% of
data set aside for Rfree). Further refinement was carried out using
REFMAC. The R and Rfree dropped further to 14.6% and 18.6%,
respectively, for data between 7.5 Å and 1.9 Å. In the final refinement,
all the data were included and the resulting R factor was 14.0%. The
model quality was analyzed using the program PROCHECK [53]. 
Accession numbers
Atomic coordinates have been deposited in the Protein Data Bank,
with the accession code 1JFR. They can also be obtained via elec-
tronic mail from zsd4n@virginia.edu.
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